Christian J Stevens-Hernandez, Sabine Kupzig, Paraskevi Diamanti, Nicola M Cogan, Allison Blair, Lesley J Bruce
{"title":"Improving the stability of cultured red blood cells during storage.","authors":"Christian J Stevens-Hernandez, Sabine Kupzig, Paraskevi Diamanti, Nicola M Cogan, Allison Blair, Lesley J Bruce","doi":"10.1111/vox.70095","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Cultured red blood cells (cRBCs) have many potential applications, including in diagnostics, as drug delivery carriers or for specialized clinical use. However, cRBCs are immature reticulocytes that do not store well. After 10 days of cold storage in saline, adenine, glucose, mannitol (SAG-M), cRBCs show around 8% haemolysis compared to <0.8% for mature RBCs. This study aimed to develop a better storage medium to enhance cRBC stability and viability.</p><p><strong>Materials and methods: </strong>cRBCs were cultured from CD34<sup>+</sup> haemopoietic cells from peripheral blood and resuspended at 1.5 × 10<sup>9</sup>/mL in SAG-M or SAG-M with different macromolecules (10% human serum albumin, 10% Dextran-40, 10% Ficoll-70). The effect of rejuvenation before storage was also investigated. Haemolysis and morphology assessment were carried out on Days 10, 16 and 20 of storage at 4°C. In vivo assays were performed by injecting 2 × 10<sup>8</sup> cRBCs into NOD.Cg-Prkdc<sup>scid</sup>Il2rγ<sup>tm1Wjl</sup>/SzJ mice on Days 1, 9 and 21 of storage. Clearance and maturation of cRBCs were assessed at different intervals post injection.</p><p><strong>Results: </strong>Addition of macromolecules significantly improved cRBC stability; 10% Dextran-40 reduced haemolysis of cRBCs to <2% over 20 days of cold storage. Rejuvenation had no significant effect. Similar numbers, morphology and maturation of cRBCs were detected in the murine circulation, whether or not stored in SAG-M or SAG-M + 10% Dx-40, regardless of storage time.</p><p><strong>Conclusion: </strong>Addition of macromolecules to SAG-M improves cRBCs storage stability and does not affect their clearance or maturation in the in vivo model. To our knowledge, this is the first report showing evidence of improved stability of cRBCs during storage.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70095","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Cultured red blood cells (cRBCs) have many potential applications, including in diagnostics, as drug delivery carriers or for specialized clinical use. However, cRBCs are immature reticulocytes that do not store well. After 10 days of cold storage in saline, adenine, glucose, mannitol (SAG-M), cRBCs show around 8% haemolysis compared to <0.8% for mature RBCs. This study aimed to develop a better storage medium to enhance cRBC stability and viability.
Materials and methods: cRBCs were cultured from CD34+ haemopoietic cells from peripheral blood and resuspended at 1.5 × 109/mL in SAG-M or SAG-M with different macromolecules (10% human serum albumin, 10% Dextran-40, 10% Ficoll-70). The effect of rejuvenation before storage was also investigated. Haemolysis and morphology assessment were carried out on Days 10, 16 and 20 of storage at 4°C. In vivo assays were performed by injecting 2 × 108 cRBCs into NOD.Cg-PrkdcscidIl2rγtm1Wjl/SzJ mice on Days 1, 9 and 21 of storage. Clearance and maturation of cRBCs were assessed at different intervals post injection.
Results: Addition of macromolecules significantly improved cRBC stability; 10% Dextran-40 reduced haemolysis of cRBCs to <2% over 20 days of cold storage. Rejuvenation had no significant effect. Similar numbers, morphology and maturation of cRBCs were detected in the murine circulation, whether or not stored in SAG-M or SAG-M + 10% Dx-40, regardless of storage time.
Conclusion: Addition of macromolecules to SAG-M improves cRBCs storage stability and does not affect their clearance or maturation in the in vivo model. To our knowledge, this is the first report showing evidence of improved stability of cRBCs during storage.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.